News briefing: Four biotechs announce IPO terms, setting the pace to round out a busy year; FDA sets PDUFA date for Kadmon's graft-versus-host drug
Four more biotechs set the terms for their IPOs, lining up yet another busy week on Wall Street.
Silverback Therapeutics, which initially filed for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
